These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 28208534)

  • 1. Re: Hyperoxaluria Requires TNF Receptors to Initiate Crystal Adhesion and Kidney Stone Disease.
    Assimos DG
    J Urol; 2017 Mar; 197(3 Pt 1):736-737. PubMed ID: 28208534
    [No Abstract]   [Full Text] [Related]  

  • 2. Stones: TNFRs mediate CaOx deposition in hyperoxaluria.
    Carney EF
    Nat Rev Nephrol; 2016 Nov; 12(11):651. PubMed ID: 27665926
    [No Abstract]   [Full Text] [Related]  

  • 3. Minipump induced hyperoxaluria and crystal deposition in rats: a model for calcium oxalate urolithiasis.
    Marengo SR; Chen D; MacLennan GT; Resnick MI; Jacobs GH
    J Urol; 2004 Mar; 171(3):1304-8. PubMed ID: 14767338
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Secondary hyperoxaluria: a risk factor for kidney stone formation and renal failure in native kidneys and renal grafts.
    Karaolanis G; Lionaki S; Moris D; Palla VV; Vernadakis S
    Transplant Rev (Orlando); 2014 Oct; 28(4):182-7. PubMed ID: 24999029
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Unusual morphology of calcium oxalate calculi in primary hyperoxaluria.
    Daudon M; Estepa L; Lacour B; Jungers P
    J Nephrol; 1998; 11 Suppl 1():51-5. PubMed ID: 9604812
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PRIMARY hyperoxaluria and oxalosis.
    Nutr Rev; 1959 Apr; 17(4):104-7. PubMed ID: 13644806
    [No Abstract]   [Full Text] [Related]  

  • 7. A new animal model of hyperoxaluria and nephrolithiasis in rats with small bowel resection.
    Worcester EM; Chuang M; Laven B; Orvieto M; Coe FL; Evan AP; Gerber GS
    Urol Res; 2005 Nov; 33(5):380-2. PubMed ID: 16284881
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hyperoxaluria in kidney stone formers treated with modern bariatric surgery.
    Asplin JR; Coe FL
    J Urol; 2007 Feb; 177(2):565-9. PubMed ID: 17222634
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hyperoxaluria leads to dysbiosis and drives selective enrichment of oxalate metabolizing bacterial species in recurrent kidney stone endures.
    Suryavanshi MV; Bhute SS; Jadhav SD; Bhatia MS; Gune RP; Shouche YS
    Sci Rep; 2016 Oct; 6():34712. PubMed ID: 27708409
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Re: Surgical Management of Stone Disease in Patients with Primary Hyperoxaluria.
    Assimos DG
    J Urol; 2016 Jan; 195(1):104-5. PubMed ID: 26699967
    [No Abstract]   [Full Text] [Related]  

  • 11. Re: Surgical Management of Stone Disease in Patients with Primary Hyperoxaluria.
    Assimos DG
    J Urol; 2015 Oct; 194(4):1014-5. PubMed ID: 26382785
    [No Abstract]   [Full Text] [Related]  

  • 12. Vitamin E therapy prevents hyperoxaluria-induced calcium oxalate crystal deposition in the kidney by improving renal tissue antioxidant status.
    Thamilselvan S; Menon M
    BJU Int; 2005 Jul; 96(1):117-26. PubMed ID: 15963133
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Re: defining variation in urinary oxalate in hyperoxaluric stone formers.
    Assimos DG
    J Urol; 2014 Jun; 191(6):1811-2. PubMed ID: 25280291
    [No Abstract]   [Full Text] [Related]  

  • 14. Early onset of stone diseases and primary hyperoxaluria.
    Topaloglu R; Bakkaloglu A; Saatci U; Besbas N
    Paediatr Indones; 1990; 30(1-2):54-8. PubMed ID: 2284120
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Oxalate: a poorly soluble organic waste with consequences].
    Lu Y; Bonny O
    Praxis (Bern 1994); 2015 Mar; 104(7):353-9. PubMed ID: 25804778
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence of hyperoxaluria in idiopathic calcium oxalate kidney stone disease.
    Baggio B; Gambaro G; Favaro S; Borsatti A
    Nephron; 1983; 35(1):11-4. PubMed ID: 6888620
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Type I primary hyperoxaluria associated with type I renal tubular acidosis.
    Cheng JH; Fu YK; Chen WP; Hwang BT; Chen SM; Lin CY
    Int J Pediatr Nephrol; 1987; 8(4):235-8. PubMed ID: 3449474
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of sodium restriction in recurrent stone formers with hyperoxaluria.
    Garg N; Steinman TI
    Am J Kidney Dis; 2014 Sep; 64(3):478. PubMed ID: 25150857
    [No Abstract]   [Full Text] [Related]  

  • 19. In reply to 'Role of sodium restriction in recurrent stone formers with hyperoxaluria'.
    Noori N; Goldfarb DS; Basiri A
    Am J Kidney Dis; 2014 Sep; 64(3):478-9. PubMed ID: 25150856
    [No Abstract]   [Full Text] [Related]  

  • 20. Oxalate metabolism in renal stone disease with special reference to calcium metabolism and intestinal absorption.
    Lindsjö M
    Scand J Urol Nephrol Suppl; 1989; 119():1-53. PubMed ID: 2669121
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.